Pemphigus Vulgaris Market (2025 - 2033) Size, Share & Trends Analysis Report By Therapy Type (Anti-CD20 Monoclonal Antibodies, Systemic Corticosteroids, Topical therapies), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Region, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Therapy Type
                        1.2.2. Distribution Channel
                    1.3. Estimates and Forecast Timeline
                    1.4. Research Methodology
                    1.5. Information Procurement
                        1.5.1. Purchased Database
                        1.5.2. GVR’s Internal Database
                        1.5.3. Secondary Sources
                        1.5.4. Primary Research
                    1.6. Information Analysis
                        1.6.1. Data Analysis Models
                    1.7. Market Formulation & Data Visualization
                    1.8. Model Details
                        1.8.1. Commodity Flow Analysis
                    1.9. List of Secondary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. Pemphigus Vulgaris Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                        3.2.2. Market Restraint Analysis
                    3.3. Business Environment Analysis
                        3.3.1. Industry Analysis - Porter’s Five Forces Analysis
                            3.3.1.1. Supplier Power
                            3.3.1.2. Buyer Power
                            3.3.1.3. Substitution Threat
                            3.3.1.4. Threat of New Entrants
                            3.3.1.5. Competitive Rivalry
                        3.3.2. PESTLE Analysis
                        3.3.3. Pipeline Analysis
Chapter 4. Pemphigus Vulgaris Market: Therapy Type Business Analysis
                    4.1. Therapy Type Market Share, 2024 & 2033
                    4.2. Therapy Type Segment Dashboard
                    4.3. Market Size & Forecasts and Trend Analysis, by Therapy Type, 2021 to 2033 (USD Million)
                    4.4. Anti-CD20 monoclonal antibodies (rituximab)
                        4.4.1. Market Estimates & Forecasts, 2021 - 2033 (USD Million)
                    4.5. Systemic corticosteroids
                        4.5.1. Market Estimates & Forecasts, 2021 - 2033 (USD Million)
                    4.6. Conventional steroid-sparing immunosuppressants
                        4.6.1. Market Estimates & Forecasts, 2021 - 2033 (USD Million)
                    4.7. Intravenous immunoglobulin (IVIG) - adjunct
                        4.7.1. Market Estimates & Forecasts, 2021 - 2033 (USD Million)
                    4.8. Topical therapies
                        4.8.1. Market Estimates & Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Pemphigus Vulgaris Market: Distribution Channel Business Analysis
                    5.1. Distribution Channel Market Share, 2024 & 2033
                    5.2. Distribution Channel Segment Dashboard
                    5.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
                    5.4. Hospital Pharmacies
                        5.4.1. Market Estimates & Forecasts, 2021 - 2033 (USD Million)
                    5.5. Retail Pharmacies
                        5.5.1. Market Estimates & Forecasts, 2021 - 2033 (USD Million)
                    5.6. Others
                        5.6.1. Market Estimates & Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Pemphigus Vulgaris Market: Regional Estimates & Trend Analysis
                    6.1. Regional Market Share Analysis, 2024 & 2033
                    6.2. Regional Market Dashboard
                    6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033
                    6.4. North America
                        6.4.1. North America Pemphigus Vulgaris Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
                        6.4.2. U.S.
                            6.4.2.1. Key Country Dynamics
                            6.4.2.2. Regulatory Framework
                            6.4.2.3. Reimbursement Framework
                            6.4.2.4. U.S. Pemphigus Vulgaris Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.4.3. Canada
                            6.4.3.1. Key Country Dynamics
                            6.4.3.2. Regulatory Framework
                            6.4.3.3. Reimbursement Framework
                            6.4.3.4. U.S. Pemphigus Vulgaris Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.4.4. Mexico
                            6.4.4.1. Key Country Dynamics
                            6.4.4.2. Regulatory Framework
                            6.4.4.3. Reimbursement Framework
                            6.4.4.4. Mexico Pemphigus Vulgaris Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.5. Europe
                        6.5.1. Europe Pemphigus Vulgaris Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
                        6.5.2. UK
                            6.5.2.1. Key Country Dynamics
                            6.5.2.2. Regulatory Framework
                            6.5.2.3. Reimbursement Framework
                            6.5.2.4. UK Pemphigus Vulgaris Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.5.3. Germany
                            6.5.3.1. Key Country Dynamics
                            6.5.3.2. Regulatory Framework
                            6.5.3.3. Reimbursement Framework
                            6.5.3.4. Germany Pemphigus Vulgaris Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.5.4. France
                            6.5.4.1. Key Country Dynamics
                            6.5.4.2. Regulatory Framework
                            6.5.4.3. Reimbursement Framework
                            6.5.4.4. France Pemphigus Vulgaris Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.5.5. Italy
                            6.5.5.1. Key Country Dynamics
                            6.5.5.2. Regulatory Framework
                            6.5.5.3. Reimbursement Framework
                            6.5.5.4. Italy Pemphigus Vulgaris Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.5.6. Spain
                            6.5.6.1. Key Country Dynamics
                            6.5.6.2. Regulatory Framework
                            6.5.6.3. Reimbursement Framework
                            6.5.6.4. Spain Pemphigus Vulgaris Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.5.7. Denmark
                            6.5.7.1. Key Country Dynamics
                            6.5.7.2. Regulatory Framework
                            6.5.7.3. Reimbursement Framework
                            6.5.7.4. Denmark Pemphigus Vulgaris Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.5.8. Sweden
                            6.5.8.1. Key Country Dynamics
                            6.5.8.2. Regulatory Framework
                            6.5.8.3. Reimbursement Framework
                            6.5.8.4. Sweden Pemphigus Vulgaris Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.5.9. Norway
                            6.5.9.1. Key Country Dynamics
                            6.5.9.2. Regulatory Framework
                            6.5.9.3. Reimbursement Framework
                            6.5.9.4. Norway Pemphigus Vulgaris Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.6. Asia Pacific
                        6.6.1. Asia Pacific Pemphigus Vulgaris Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
                        6.6.2. Japan
                            6.6.2.1. Key Country Dynamics
                            6.6.2.2. Regulatory Framework
                            6.6.2.3. Reimbursement Framework
                            6.6.2.4. Japan Pemphigus Vulgaris Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.6.3. China
                            6.6.3.1. Key Country Dynamics
                            6.6.3.2. Regulatory Framework
                            6.6.3.3. Reimbursement Framework
                            6.6.3.4. China Pemphigus Vulgaris Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.6.4. India
                            6.6.4.1. Key Country Dynamics
                            6.6.4.2. Regulatory Framework
                            6.6.4.3. Reimbursement Framework
                            6.6.4.4. India Pemphigus Vulgaris Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.6.5. Australia
                            6.6.5.1. Key Country Dynamics
                            6.6.5.2. Regulatory Framework
                            6.6.5.3. Reimbursement Framework
                            6.6.5.4. Australia Pemphigus Vulgaris Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.6.6. South Korea
                            6.6.6.1. Key Country Dynamics
                            6.6.6.2. Regulatory Framework
                            6.6.6.3. Reimbursement Framework
                            6.6.6.4. South Korea Pemphigus Vulgaris Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.6.7. Thailand
                            6.6.7.1. Key Country Dynamics
                            6.6.7.2. Regulatory Framework
                            6.6.7.3. Reimbursement Framework
                            6.6.7.4. Thailand Pemphigus Vulgaris Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.7. Latin America
                        6.7.1. Latin America Pemphigus Vulgaris Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
                        6.7.2. Brazil
                            6.7.2.1. Key Country Dynamics
                            6.7.2.2. Regulatory Framework
                            6.7.2.3. Reimbursement Framework
                            6.7.2.4. Brazil Pemphigus Vulgaris Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.7.3. Argentina
                            6.7.3.1. Key Country Dynamics
                            6.7.3.2. Regulatory Framework
                            6.7.3.3. Reimbursement Framework
                            6.7.3.4. Argentina Pemphigus Vulgaris Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.8. Middle East and Africa
                        6.8.1. Middle East and Africa Pemphigus Vulgaris Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
                        6.8.2. South Africa
                            6.8.2.1. Key Country Dynamics
                            6.8.2.2. Regulatory Framework
                            6.8.2.3. Reimbursement Framework
                            6.8.2.4. South Africa Pemphigus Vulgaris Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.8.3. Saudi Arabia
                            6.8.3.1. Key Country Dynamics
                            6.8.3.2. Regulatory Framework
                            6.8.3.3. Reimbursement Framework
                            6.8.3.4. Saudi Arabia Pemphigus Vulgaris Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.8.4. UAE
                            6.8.4.1. Key Country Dynamics
                            6.8.4.2. Regulatory Framework
                            6.8.4.3. Reimbursement Framework
                            6.8.4.4. UAE Pemphigus Vulgaris Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.8.5. Kuwait
                            6.8.5.1. Key Country Dynamics
                            6.8.5.2. Regulatory Framework
                            6.8.5.3. Reimbursement Framework
                            6.8.5.4. Kuwait Pemphigus Vulgaris Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
                    7.1. Participant Overview
                    7.2. Company Market Position Analysis
                    7.3. Company Categorization
                    7.4. Strategy Mapping
                    7.5. Company Profiles/Listing
                        7.5.1. Genentech, Inc.
                            7.5.1.1. Overview
                            7.5.1.2. Financial Performance
                            7.5.1.3. Product Benchmarking
                            7.5.1.4. Strategic Initiatives
                        7.5.2. Pfizer Inc.
                            7.5.2.1. Overview
                            7.5.2.2. Financial Performance
                            7.5.2.3. Product Benchmarking
                            7.5.2.4. Strategic Initiatives
                        7.5.3. CELLTRION INC.
                            7.5.3.1. Overview
                            7.5.3.2. Financial Performance
                            7.5.3.3. Product Benchmarking
                            7.5.3.4. Strategic Initiatives
                        7.5.4. Amgen Inc.
                            7.5.4.1. Overview
                            7.5.4.2. Financial Performance
                            7.5.4.3. Product Benchmarking
                            7.5.4.4. Strategic Initiatives
                        7.5.5. Zenyaku Kogyo Co.
                            7.5.5.1. Overview
                            7.5.5.2. Financial Performance
                            7.5.5.3. Product Benchmarking
                            7.5.5.4. Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global pemphigus vulgaris market, by region, 2021 - 2033 (USD Million)
Table 4 Global pemphigus vulgaris market, by therapy type, 2021 - 2033 (USD Million)
Table 5 Global pemphigus vulgaris market, by distribution channel, 2021 - 2033 (USD Million)
Table 6 North America pemphigus vulgaris market, by country, 2021 - 2033 (USD Million)
Table 7 North America pemphigus vulgaris market, by therapy type, 2021 - 2033 (USD Million)
Table 8 North America pemphigus vulgaris market, by distribution channel, 2021 - 2033 (USD Million)
Table 9 US pemphigus vulgaris market, by therapy type, 2021 - 2033 (USD Million)
Table 10 US pemphigus vulgaris market, by distribution channel, 2021 - 2033 (USD Million)
Table 11 Canada pemphigus vulgaris market, by therapy type, 2021 - 2033 (USD Million)
Table 12 Canada pemphigus vulgaris market, by distribution channel, 2021 - 2033 (USD Million)
Table 13 Mexico pemphigus vulgaris market, by therapy type, 2021 - 2033 (USD Million)
Table 14 Mexico pemphigus vulgaris market, by distribution channel, 2021 - 2033 (USD Million)
Table 15 Europe pemphigus vulgaris market, by country, 2021 - 2033 (USD Million)
Table 16 Europe pemphigus vulgaris market, by therapy type, 2021 - 2033 (USD Million)
Table 17 Europe pemphigus vulgaris market, by distribution channel, 2021 - 2033 (USD Million)
Table 18 UK pemphigus vulgaris market, by therapy type, 2021 - 2033 (USD Million)
Table 19 UK pemphigus vulgaris market, by distribution channel, 2021 - 2033 (USD Million)
Table 20 Germany pemphigus vulgaris market, by therapy type, 2021 - 2033 (USD Million)
Table 21 Germany pemphigus vulgaris market, by distribution channel, 2021 - 2033 (USD Million)
Table 22 France pemphigus vulgaris market, by therapy type, 2021 - 2033 (USD Million)
Table 23 France pemphigus vulgaris market, by distribution channel, 2021 - 2033 (USD Million)
Table 24 Italy pemphigus vulgaris market, by therapy type, 2021 - 2033 (USD Million)
Table 25 Italy pemphigus vulgaris market, by distribution channel, 2021 - 2033 (USD Million)
Table 26 Spain pemphigus vulgaris market, by therapy type, 2021 - 2033 (USD Million)
Table 27 Spain pemphigus vulgaris market, by distribution channel, 2021 - 2033 (USD Million)
Table 28 Denmark pemphigus vulgaris market, by therapy type, 2021 - 2033 (USD Million)
Table 29 Denmark pemphigus vulgaris market, by distribution channel, 2021 - 2033 (USD Million)
Table 30 Sweden pemphigus vulgaris market, by therapy type, 2021 - 2033 (USD Million)
Table 31 Sweden pemphigus vulgaris market, by distribution channel, 2021 - 2033 (USD Million)
Table 32 Norway pemphigus vulgaris market, by therapy type, 2021 - 2033 (USD Million)
Table 33 Norway pemphigus vulgaris market, by distribution channel, 2021 - 2033 (USD Million)
Table 34 Asia Pacific pemphigus vulgaris market, by country, 2021 - 2033 (USD Million)
Table 35 Asia Pacific pemphigus vulgaris market, by therapy type, 2021 - 2033 (USD Million)
Table 36 Asia Pacific pemphigus vulgaris market, by distribution channel, 2021 - 2033 (USD Million)
Table 37 Japan pemphigus vulgaris market, by therapy type, 2021 - 2033 (USD Million)
Table 38 Japan pemphigus vulgaris market, by distribution channel, 2021 - 2033 (USD Million)
Table 39 China pemphigus vulgaris market, by therapy type, 2021 - 2033 (USD Million)
Table 40 China pemphigus vulgaris market, by distribution channel, 2021 - 2033 (USD Million)
Table 41 India pemphigus vulgaris market, by therapy type, 2021 - 2033 (USD Million)
Table 42 India pemphigus vulgaris market, by distribution channel, 2021 - 2033 (USD Million)
Table 43 Australia pemphigus vulgaris market, by therapy type, 2021 - 2033 (USD Million)
Table 44 Australia pemphigus vulgaris market, by distribution channel, 2021 - 2033 (USD Million)
Table 45 South Korea pemphigus vulgaris market, by therapy type, 2021 - 2033 (USD Million)
Table 46 South Korea pemphigus vulgaris market, by distribution channel, 2021 - 2033 (USD Million)
Table 47 Thailand pemphigus vulgaris market, by therapy type, 2021 - 2033 (USD Million)
Table 48 Thailand pemphigus vulgaris market, by distribution channel, 2021 - 2033 (USD Million)
Table 49 Latin America pemphigus vulgaris market, by country, 2021 - 2033 (USD Million)
Table 50 Latin America pemphigus vulgaris market, by therapy type, 2021 - 2033 (USD Million)
Table 51 Latin America pemphigus vulgaris market, by distribution channel, 2021 - 2033 (USD Million)
Table 52 Brazil pemphigus vulgaris market, by therapy type, 2021 - 2033 (USD Million)
Table 53 Brazil pemphigus vulgaris market, by distribution channel, 2021 - 2033 (USD Million)
Table 54 Argentina pemphigus vulgaris market, by therapy type, 2021 - 2033 (USD Million)
Table 55 Argentina pemphigus vulgaris market, by distribution channel, 2021 - 2033 (USD Million)
Table 56 Middle East & Africa pemphigus vulgaris market, by country, 2021 - 2033 (USD Million)
Table 57 Middle East & Africa pemphigus vulgaris market, by therapy type, 2021 - 2033 (USD Million)
Table 58 Middle East & Africa pemphigus vulgaris market, by distribution channel, 2021 - 2033 (USD Million)
Table 59 South Africa pemphigus vulgaris market, by therapy type, 2021 - 2033 (USD Million)
Table 60 South Africa pemphigus vulgaris market, by distribution channel, 2021 - 2033 (USD Million)
Table 61 Saudi Arabia pemphigus vulgaris market, by therapy type, 2021 - 2033 (USD Million)
Table 62 Saudi Arabia pemphigus vulgaris market, by distribution channel, 2021 - 2033 (USD Million)
Table 63 UAE pemphigus vulgaris market, by therapy type, 2021 - 2033 (USD Million)
Table 64 UAE pemphigus vulgaris market, by distribution channel, 2021 - 2033 (USD Million)
Table 65 Kuwait pemphigus vulgaris market, by therapy type, 2021 - 2033 (USD Million)
Table 66 Kuwait pemphigus vulgaris market, by distribution channel, 2021 - 2033 (USD Million) 

List of Figures

Fig. 1 Pemphigus vulgaris market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Therapeutic approach and disease outlook (USD Million)
Fig. 10 Competitive landscape
Fig. 11 Pemphigus vulgaris market dynamics
Fig. 12 Pemphigus vulgaris market: Porter’s five forces analysis
Fig. 13 Pemphigus vulgaris market: PESTLE analysis
Fig. 14 Pemphigus vulgaris market: Therapy type movement analysis
Fig. 15 Pemphigus vulgaris market: Therapy type outlook and key takeaways
Fig. 16 Anti-CD20 monoclonal antibodies (rituximab) market estimates and forecast, 2021 - 2033
Fig. 17 Systemic corticosteroids market estimates and forecast, 2021 - 2033
Fig. 18 Conventional steroid-sparing immunosuppressants market estimates and forecast, 2021 - 2033
Fig. 19 Intravenous immunoglobulin (IVIG) - adjunct market estimates and forecast, 2021 - 2033
Fig. 20 Topical therapies market estimates and forecast, 2021 - 2033
Fig. 21 Pemphigus vulgaris market: Distribution channel movement analysis
Fig. 22 Pemphigus vulgaris market: Distribution channel outlook and key takeaways
Fig. 23 Hospital Pharmacies market estimates and forecast, 2021 - 2033
Fig. 24 Retail pharmacies market estimates and forecast, 2021 - 2033
Fig. 25 OtherOthers market estimates and forecast, 2021 - 2033
Fig. 26 Pemphigus vulgaris market: Regional movement analysis
Fig. 27 Pemphigus vulgaris market: Regional outlook and key takeaways
Fig. 28 North America market estimates and forecast, 2021 - 2033
Fig. 29 U.S. market estimates and forecast, 2021 - 2033
Fig. 30 Canada market estimates and forecast, 2021 - 2033
Fig. 31 Mexico market estimates and forecast, 2021 - 2033
Fig. 32 Europe market estimates and forecast, 2021 - 2033
Fig. 33 UK market estimates and forecast, 2021 - 2033
Fig. 34 Germany market estimates and forecast, 2021 - 2033
Fig. 35 France market estimates and forecast, 2021 - 2033
Fig. 36 Italy market estimates and forecast, 2021 - 2033
Fig. 37 Spain market estimates and forecast, 2021 - 2033
Fig. 38 Denmark market estimates and forecast, 2021 - 2033
Fig. 39 Sweden market estimates and forecast, 2021 - 2033
Fig. 40 Norway market estimates and forecast, 2021 - 2033
Fig. 41 Asia Pacific market estimates and forecast, 2021 - 2033
Fig. 42 Japan market estimates and forecast, 2021 - 2033
Fig. 43 China market estimates and forecast, 2021 - 2033
Fig. 44 India market estimates and forecast, 2021 - 2033
Fig. 45 Australia market estimates and forecast, 2021 - 2033
Fig. 46 South Korea market estimates and forecast, 2021 - 2033
Fig. 47 Thailand market estimates and forecast, 2021 - 2033
Fig. 48 Latin America market estimates and forecast, 2021 - 2033
Fig. 49 Brazil market estimates and forecast, 2021 - 2033
Fig. 50 Argentina market estimates and forecast, 2021 - 2033
Fig. 51 Middle East & Africa market estimates and forecast, 2021 - 2033
Fig. 52 South Africa market estimates and forecast, 2021 - 2033
Fig. 53 Saudi Arabia market estimates and forecast, 2021 - 2033
Fig. 54 UAE market estimates and forecast, 2021 - 2033
Fig. 55 Kuwait market estimates and forecast, 2021 - 2033
Fig. 56 Company categorization
Fig. 57 Company market position analysis
Fig. 58 Strategic framework